The present study investigates the potential ameliorative effects of ethyl and aqueous fractions derived from methanol extract in disease management. In this research, we explore the therapeutic properties of these fractions and their impact on mitigating various health conditions. The study employed a combination of in vitro and in vivo experiments to assess the bioactive components and evaluate the efficacy of these fractions in improving health outcomes. the ameliorative potential of ethyl and aqueous fractions derived from the methanol extract in the context of disease management. The study investigates the therapeutic efficacy of these fractions in mitigating the impact of a specific disease, employing rigorous experimental methods and analyses. The ethyl and aqueous fractions were isolated from the methanol extract, and their effects on disease-related parameters were systematically evaluated. Results indicate promising ameliorative properties, suggesting the potential application of these fractions as therapeutic agents. The findings contribute valuable insights to the field of disease management, emphasizing the significance of natural compounds derived from methanol extraction in developing novel and effective interventions. This research lays the groundwork for further exploration and application of ethyl and aqueous fractions in pharmaceutical and healthcare contexts, offering potential avenues for the development of targeted therapeutic strategies.